Autoantibodies in patients with chronic obstructive pulmonary disease

CA Feghali-Bostwick, AS Gadgil… - American journal of …, 2008 - atsjournals.org
CA Feghali-Bostwick, AS Gadgil, LE Otterbein, JM Pilewski, MW Stoner, E Csizmadia…
American journal of respiratory and critical care medicine, 2008atsjournals.org
Rationale: Adaptive immune responses are present in patients with chronic obstructive
pulmonary disease (COPD), and it has been postulated that these processes could be
autoreactive. Objectives: To ascertain if humoral autoimmunity could play a role in COPD
pathogenesis. Methods: Circulating IgG autoantibodies were detected by
immunofluorescence and immunoprecipitation. Immunohistochemistry and
immunofluorescence were used to evaluate intrapulmonary IgG and complement (C3) …
Rationale: Adaptive immune responses are present in patients with chronic obstructive pulmonary disease (COPD), and it has been postulated that these processes could be autoreactive.
Objectives: To ascertain if humoral autoimmunity could play a role in COPD pathogenesis.
Methods: Circulating IgG autoantibodies were detected by immunofluorescence and immunoprecipitation. Immunohistochemistry and immunofluorescence were used to evaluate intrapulmonary IgG and complement (C3) deposition in human lung explants. Autoantibody pathogenicity was also investigated with an antibody-dependent cell-mediated cytotoxicity assay.
Measurements and Main Results: The prevalence of anti–HEp-2 epithelial cell autoantibodies in 47 smokers/former smokers with COPD (GOLD stages 1–4) was greater than among 8 subjects with a smoking history but normal spirometry and 21 healthy control subjects who had never smoked (68 vs. 13 vs. 10%, respectively; P < 0.0001). Antibodies against primary pulmonary epithelial cells were found in 12 of 12 patients with COPD versus 3 of 12 never-smoked control subjects (P < 0.001). Self-antigens immunoprecipitated from 34 of 35 (97%) of COPD plasmas (vs. 0/12 never-smoked controls). Antibodies against a particular 130-kD autoantigen (n = 7) were associated with decreased body mass index (23.2 ± 2.1 vs. 29.5 ± 1.0 kg/m2, P = 0.007). Intrapulmonary immune complexes were present in six of six and C3 was seen in five of six COPD lung explants, unlike zero of six and one of six normals, respectively. Cytotoxicity of pulmonary epithelial cells by allogeneic mononuclear cells also increased 46% after incubation with COPD plasmas (n = 10), compared with identical treatments with eight normal specimens (P = 0.03).
Conclusions: IgG autoantibodies with avidity for pulmonary epithelium, and the potential to mediate cytotoxicity, are prevalent in patients with COPD. Autoreactive adaptive immune responses may be important in the etiology of this disease.
ATS Journals